Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2004 | 06-2004 | 03-2004 | 12-2003 | 09-2003 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 105,047 | 122,833 | 174,034 | 118,285 | 298,617 |
| Marketable Securities | 173,668 | 221,217 | 146,702 | 175,489 | 86,056 |
| Receivables | 24,866 | 25,397 | 59,882 | 15,529 | 9,197 |
| Inventories | 4,266 | 10,850 | 9,098 | 9,006 | 7,698 |
| TOTAL | $311,238 | $383,330 | $392,284 | $320,207 | $404,378 |
| Non-Current Assets | |||||
| PPE Net | 73,942 | 75,986 | 77,616 | 80,723 | 83,715 |
| Investments And Advances | 82,469 | 23,623 | 30,642 | 72,792 | 6,450 |
| Other Non-Current Assets | 5,036 | 5,235 | 5,636 | 5,833 | 5,958 |
| TOTAL | $161,447 | $104,844 | $113,894 | $159,348 | $96,123 |
| Total Assets | $472,685 | $488,174 | $506,178 | $479,555 | $500,501 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 20,284 | 15,743 | 18,947 | 18,933 | 20,967 |
| TOTAL | $35,900 | $37,372 | $36,335 | $72,923 | $54,736 |
| Non-Current Liabilities | |||||
| Long Term Debt | 200,000 | 200,000 | 200,000 | 200,000 | 200,000 |
| Deferred Revenues | 15,616 | 21,629 | 17,388 | 40,173 | 24,473 |
| aiOther Non-Current Liabilities | 36 | 74 | 116 | 159 | 0 |
| TOTAL | $257,912 | $260,672 | $265,737 | $268,989 | $289,563 |
| Total Liabilities | $293,812 | $298,044 | $302,072 | $341,912 | $344,299 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 55,742 | 55,693 | 55,643 | 55,563 | 55,301 |
| Common Shares | 55 | 55 | 55 | 55 | 55 |
| Retained earnings | -492,626 | -481,550 | -467,001 | -531,533 | -512,156 |
| Other shareholders' equity | -2,191 | -2,880 | -3,190 | -3,997 | -1,817 |
| TOTAL | $178,873 | $190,130 | $204,106 | $137,643 | $156,202 |
| Total Liabilities And Equity | $472,685 | $488,174 | $506,178 | $479,555 | $500,501 |